Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
2,043,812
-
Share change
-
-33,149
-
Total reported value
-
$2,614,244
-
Put/Call ratio
-
0%
-
Price per share
-
$1.28
-
Number of holders
-
23
-
Value change
-
-$42,880
-
Number of buys
-
7
-
Number of sells
-
6
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2024
As of 30 Sep 2024,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,043,812 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Cresset Asset Management, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.